Cancers, Vol. 12, Pages 467: Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Due to Suppressed Double-Strand Break (DSB) Repair by Non-Homologous End Joining
Cancers, Vol. 12, Pages 467: Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Radiosensitivity of Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Due to Suppressed Double-Strand Break (DSB) Repair by Non-Homologous End Joining
Cancers doi: 10.3390/cancers12020467
Authors:
Schötz
Balzer
Brandt
Ziemann
Subtil
Rieckmann
Köcher
Engenhart-Cabillic
Dikomey
Wittig
Arenz
The PI3K/Akt/mTOR pathway is frequently altered in human papillomavirus (HPV)-positive and negative squamous cell carcinoma of the head and neck (HNSCC) and overstimulation is associated with poor prognosis. PI3K drives Akt activation and constitutive signaling acts pro-proliferative, supports cell survival, DNA repair, and contributes to radioresistance. Since the small molecule NVP-BEZ235 (BEZ235) is a potent dual inhibitor of this pathway, we were interested whether BEZ235 could be an efficient radiosensitizer. The 50 nM BEZ235 was found to abrogate endogenous and irradiation-induced phosphorylation of Akt (Ser473). The anti-proliferative capacity of the drug resulted in an increase in G1-phase cells. Repair of radiation-induced DNA double-strand breaks (DSBs) was strongly suppressed. Reduction in DSB repair was only apparent in G1- but not in G2-phase cells, suggesting that BEZ235 primarily affects non-homologous end joining. This finding was confirmed using a DSB repair reporter gene assay and could be attributed to an impaired phosphorylation of DNA-PKcs (S2056). Ce...
Source: Cancers - Category: Cancer & Oncology Authors: Sch ötz Balzer Brandt Ziemann Subtil Rieckmann K öcher Engenhart-Cabillic Dikomey Wittig Arenz Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Gastroschisis Repair | Genetics | Genital Warts | Head and Neck Cancer | HNSCC | Human Papillomavirus (HPV) | Skin Cancer | Squamous Cell Carcinoma